We are live on
!
Find out more
WA
WESPAC Advisors Portfolio holdings
AUM
$183M
1-Year Est. Return
29.81%
This Fund
S&P 500
This Quarter
Est. Return
+8.18%
1 Year Est. Return
+29.81%
3 Year Est. Return
+84.48%
5 Year Est. Return
+101.16%
10 Year Est. Return
+413.59%
AUM
$172M
AUM Growth
+$27.7M
(+19%)
Cap. Flow
+$17.6M
Cap. Flow
% of AUM
10.25%
Top 10 Holdings %
Top 10 Hldgs %
24.79%
Holding
186
New
34
Increased
67
Reduced
48
Closed
19
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Regan Floating Rate MBS ETF
MBSF
|
+$1.94M |
| 2 |
Invesco S&P 500 Momentum ETF
SPMO
|
+$1.51M |
| 3 |
SPDR Gold Trust
GLD
|
+$1.25M |
| 4 |
Chevron
CVX
|
+$1.22M |
| 5 |
ExxonMobil
XOM
|
+$1.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 0-3 Month Treasury Bond ETF
SGOV
|
+$1.45M |
| 2 |
AstraZeneca
AZN
|
+$901K |
| 3 |
Nike
NKE
|
+$815K |
| 4 |
ProShares Short High Yield
SJB
|
+$663K |
| 5 |
Merck
MRK
|
+$608K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 11.51% |
| 2 | Healthcare | 7.53% |
| 3 | Energy | 6.39% |
| 4 | Financials | 5.82% |
| 5 | Industrials | 4.53% |
Similar funds
MAM
ACG
CF
QC
SPI
RMC
MCM
BWA
WESPAC Advisors's Q1 2024 Portfolio in Review
As of Q1 2024, WESPAC Advisors held 186 positions worth $172M, up 19% from $144M the previous quarter. Its ten largest holdings account for 25% of the portfolio.
WESPAC Advisors deployed $17.6M of net new capital in Q1 2024, opening 34 new positions and adding to 67 existing holdings. Its largest new stake was Regan Floating Rate MBS ETF: 76,927 shares worth $1.94M.
By sector, the portfolio is most concentrated in Technology at 12% of assets, up from 10% a quarter earlier, followed by Healthcare and Energy.
On the sell side, the largest reduction was AstraZeneca, an estimated $901K trimmed.
- WESPAC Advisors's largest Q1 2024 buy was Regan Floating Rate MBS ETF: 76,927 shares worth $1.94M.
- WESPAC Advisors added most to SPDR Gold Trust in Q1 2024, an estimated $1.25M increase.
- WESPAC Advisors's biggest Q1 2024 reduction was AstraZeneca, cutting an estimated $901K.
- WESPAC Advisors fully exited iShares 0-3 Month Treasury Bond ETF in Q1 2024, selling an estimated $1.45M.
- WESPAC Advisors's ten largest holdings make up 25% of its $172M portfolio in Q1 2024.
- WESPAC Advisors opened 34 new positions and closed 19 in Q1 2024.
- WESPAC Advisors's portfolio value rose 19% quarter-over-quarter to $172M.
Based on WESPAC Advisors's 13F filing for Q1 2024, filed 24 Apr 2024.